<DOC>
	<DOCNO>NCT00897663</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor identify learn biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This laboratory study look tissue sample patient glioblastoma multiforme identify biomarkers may improve selection patient epidermal growth factor receptor inhibitor therapy .</brief_summary>
	<brief_title>Improving Selection Patients With Glioblastoma Multiforme Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies</brief_title>
	<detailed_description>OBJECTIVES : Primary - Identify molecular characteristic predict overall survival progression-free survival patient treat erlotinib hydrochloride , temozolomide , radiotherapy clinical trial NCCTG-N0177 . Secondary - Identify molecular characteristic predict overall survival progression-free survival patient treat gefitinib radiotherapy clinical trial NCCTG-N0074 . OUTLINE : This multicenter study . Tissue sample patient enrol clinical trial NCCTG-N0177 NCCTG-N0074 analyze microarray analysis immunohistochemistry biological marker predict progression-free survival overall survival . Biological marker include epidermal growth factor expression , vIII mutant p53 gene , P-AKT , p7056k , S6 , 4EBP1 , STAT-3 , PLC-g , Erk , ErbB2 , ErbB3 , ErbB4 , platelet-derived growth factor receptor , IGF1R , interleukin-6 , FADD , MGMT . PROJECTED ACCRUAL : A total 120 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>All patient enter onto N0177 N0074 appropriate archive clinical specimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult glioblastoma</keyword>
</DOC>